A resource has been created by JDRF UK in association with JDRF International, JDRF Australia and the Beyond Type 1 Alliance. It will be updated
The French pharmaceutical giant Sanofi has agreed to pay digital health company Dario Health $30 million to market its diabetes products. In return, Dario Health
Dexcom’s G7 is the next-generation continuous glucose monitoring (CGM) system building on the best-selling real-time CGM in the world. It is now more powerful and
More than nine out of ten surgeons say they have pricked themselves with a contaminated needle at least once or seen a colleague do so.
Many of the UK’s biggest restaurant chains have told the Observer newspaper they won’t change their ingredients when regulations are introduced in April requiring them
A five year double-blinded study involving 26,000 over 50 year olds given vitamin D or a placebo tablet, found a high vitamin D dose cut
A successful NHS soup and shake diet is being offered to more and more people across the country as a way of achieving remission from
Following last issue’s look at the history of the discovery of insulin, this time we take a good look at what might yet happen. We
Tandem is first smartphone App to be cleared for insulin delivery by the FDA on both iOS and Android operating systems. Announced in mid-February 2022,
The American medical devices giant Becton Dickinson known as BD, has decided to spin off its Diabetes Care division and announced the name of the
